WHO ICTRP trial

The impact of transcranial direct current stimulation (tDCS) on open-label…

DRKS00037468 · German Clinical Trials Register · Not Recruiting

Key facts

Trial ID DRKS00037468
Public title The impact of transcranial direct current stimulation (tDCS) on open-label placebo effects
Scientific title The impact of transcranial direct current stimulation (tDCS) on open-label placebo effects - OLP_tDCS
Primary sponsor Medical School Berlin
Registry German Clinical Trials Register
Recruitment status Not Recruiting
Study type interventional
Countries Germany
Conditions F32.0 F32.1 F32.2 F33.0 F33.1 F33.2;Mild depressive episode;Moderate depressive episode;Severe depressive episode without psychotic symptoms;Recurrent depressive disorder, current episode mild;Recurrent depressive disorder, current episode…
Interventions Group 1: Healthy participants Intervention: Open-label placebo (nasal spray), described as a placebo Two test sessions, 4–10 days apart Each session combined with either active or sham tDCS over the DLPFC (order randomized) Group 2: Healthy…
Registration date Jul 24, 2025
Target size 20
Secondary IDs MSB-2025/239
Registry page drks.de

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations